Search

Search results: 607

RSS Subscribe to this search More...
  1. 29 Oct 2014
    Quantitative versus qualitative cultures of respiratory secretions in patients with ventilator-associated pneumonia Updated
    Review question We wanted to determine whether quantitative cultures of respiratory secretions are effective in reducing mortality in immunocompetent patients with ventilator-associated pneumonia compared with qualitative cultures. We also evaluated changes in antibiotic use, length of intensive care unit (ICU) stay and mechanical ventilation. Background Ventilator-associated ...
  2. 29 Oct 2014
    The rapid test GenoType® MTBDRsl for testing resistance to second-line TB drugs New
    Background Different drugs are available to treat people with tuberculosis (TB), but resistance to these drugs is a growing problem. People with drug-resistant TB are more likely to die than people with drug-susceptible TB. People with drug-resistant TB require "second-line" TB drugs that, compared with "first-line" TB drugs used to treat drug-susceptible ...
  3. 27 Oct 2014
    Decongestants, antihistamines and nasal irrigation for acute sinusitis in children Updated
    Review question The goal of this review was to determine whether there is any evidence in the medical literature for or against the use of decongestants, antihistamines and nasal irrigation for acute sinusitis in children. Background Young children experience an average of six to eight colds per year. Out of every 10 children with a cold, one develops ...
  4. 25 Oct 2014
    Probiotics for preventing ventilator-associated pneumonia New
    Review question To critically assess the current evidence from published studies relating to the effect of probiotics for preventing ventilator-associated pneumonia (VAP). Background VAP is a condition that can occur in patients who have been mechanically ventilated for more than 48 hours and can significantly increase the likelihood of death within ...
  5. 24 Oct 2014
    Treatments to cure long-term infections with Burkholderia cepacia in people with cystic fibrosis New
    Review question We reviewed the evidence for antibiotic treatment to cure early infection with Burkholderia cepacia complex in people with cystic fibrosis and prevent it becoming permanent. Background Cystic fibrosis is an inherited disease and people who have this disease produce large amounts of thick mucus which is difficult to clear. This mucus ...
  6. 21 Oct 2014
    Interventions for managing asthma in pregnancy New
    Asthma is the most common disorder of the respiratory system (the organs that help you breathe) in pregnancy, affecting up to one in eight women. During pregnancy asthma can improve, worsen or remain unchanged. Poorly controlled asthma may lead to complications for mothers including pre-eclampsia (high blood pressure and protein in the urine), gestational ...
  7. 19 Oct 2014
    Non-drug management of breathing problems for children with severe physical and intellectual impairment New
    Background For a variety of reasons, some children live with very severe intellectual and physical problems; they are unable to walk or talk and require a lot of care. In this study we refer to them as children with severe global developmental delay (SGDD); this is not a specific diagnosis but is rather an 'umbrella term' used to describe a group of ...
  8. 9 Oct 2014
    Antibiotics for bronchiolitis in children under two years of age Updated
    Question We reviewed the evidence on the effect of antibiotics on clinical outcomes in children with bronchiolitis. Background Bronchiolitis is a serious respiratory illness that affects babies. It is most commonly caused by respiratory syncytial virus (RSV) and is the most common reason for hospitalisation in babies younger than six months. Babies ...
  9. 9 Oct 2014
    Antibiotics for community-acquired pneumonia in adolescent and adult outpatients Updated
    Review question This review studied the effects of antibiotics on adolescents and adults with pneumonia acquired and treated in the community (as opposed to acquiring pneumonia in hospital and/or being treated for pneumonia in hospital). The evidence is current to March 2014. Background Lower respiratory tract infection is the third leading cause ...
  10. 9 Oct 2014
    Inhaled corticosteroids for cystic fibrosis Updated
    Review question We reviewed the evidence about the effect of inhaled corticosteroids in people with cystic fibrosis. Background Repeated chest infections in people with cystic fibrosis cause inflammation and damage to the lungs which, in the long term, is the most common reason for death in people with cystic fibrosis. Inhaled corticosteroids are ...

Pages

RSS Subscribe to this search More...